Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; purified talc; propylene glycol; purified water; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; potassium hydroxide; iron oxide black; titanium dioxide; gelatin; sodium lauryl sulfate; ethanol absolute - pregabalin gh is indicated for the treatment of neuropathic pain in adults. pregabalin gh is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: purified talc; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; iron oxide red; gelatin; sodium lauryl sulfate; ethanol absolute - pregabalin gh is indicated for the treatment of neuropathic pain in adults. pregabalin gh is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: purified talc; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; gelatin; sodium lauryl sulfate; ethanol absolute - pregabalin gh is indicated for the treatment of neuropathic pain in adults. pregabalin gh is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: - management of neuropathic pain associated with diabetic peripheral neuropathy - management of postherpetic neuralgia - adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older - management of fibromyalgia - management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica ® (pregabalin) capsules and oral solution products. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information r

Stati Uniti - Ingliż - NLM (National Library of Medicine)

direct_rx - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: management of neuropathic pain associated with diabetic peripheral neuropathy management of postherpetic neuralgia adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older management of fibromyalgia management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica (pregabalin) capsules. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. 8.1 pregnancy pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding th

Stati Uniti - Ingliż - NLM (National Library of Medicine)

direct_rx - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: management of neuropathic pain associated with diabetic peripheral neuropathy management of postherpetic neuralgia adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older management of fibromyalgia management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica (pregabalin) capsules. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. 8.1 pregnancy pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding th

Stati Uniti - Ingliż - NLM (National Library of Medicine)

direct_rx - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: management of neuropathic pain associated with diabetic peripheral neuropathy management of postherpetic neuralgia adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older management of fibromyalgia management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica (pregabalin) capsules. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. 8.1 pregnancy pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding th

Stati Uniti - Ingliż - NLM (National Library of Medicine)

direct_rx - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: management of neuropathic pain associated with diabetic peripheral neuropathy management of postherpetic neuralgia adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older management of fibromyalgia management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica (pregabalin) capsules. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. 8.1 pregnancy pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding th

Stati Uniti - Ingliż - NLM (National Library of Medicine)

direct_rx - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: management of neuropathic pain associated with diabetic peripheral neuropathy management of postherpetic neuralgia adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older management of fibromyalgia management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica (pregabalin) capsules. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. 8.1 pregnancy pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding th

Stati Uniti - Ingliż - NLM (National Library of Medicine)

direct_rx - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsules are indicated for: management of neuropathic pain associated with diabetic peripheral neuropathy management of postherpetic neuralgia adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older management of fibromyalgia management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer’s lyrica (pregabalin) capsules. however, due to pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. 8.1 pregnancy pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding th